Solution

At present, the company has established extensive, in-depth and long-term cooperative relationships with many hospitals, and researches on multiple cancers such as lung cancer, colorectal cancer and gynecological tumors. The research direction covers the screening of early tumor markers and the prognosis. evaluation, tumor heterogeneity molecular classification and other fields, and

achieved fruitful results.

01
Genecast Comprehensive
  • Optimizing therapy regimen and companion diagnostics for multiple solid tumors.
  • Indications: all targeted therapies for solid tumors.
02
Genecast Lung
  • Precision medication guidelines for non-small cell lung cancer.
03
Genecast CRC
  • Precision medication guidelines for colorectal cancer.
04
Genecast PD-L1
  • Protein Detection for Solid Tumors PD-L1 / PD-1 and Mismatch Repair.
05
MammaPrint
  • MammaPrint identifies patients with a genomic Low Risk of breast cancer recurrence who are unlikely to benefit from chemotherapy.